Durable Remissions with Ivosidenib inIDH1-Mutated Relapsed or Refractory AML-Reference-Cited by-同舟云学术

Durable Remissions with Ivosidenib inIDH1-Mutated Relapsed or Refractory AML

Published:2018-06-21 Issue:25 Volume:378 Page:2386-2398
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

DiNardo Courtney D.¹,Stein Eytan M.¹,de Botton Stéphane¹,Roboz Gail J.¹,Altman Jessica K.¹,Mims Alice S.¹,Swords Ronan¹,Collins Robert H.¹,Mannis Gabriel N.¹,Pollyea Daniel A.¹,Donnellan Will¹,Fathi Amir T.¹,Pigneux Arnaud¹,Erba Harry P.¹,Prince Gabrielle T.¹,Stein Anthony S.¹,Uy Geoffrey L.¹,Foran James M.¹,Traer Elie¹,Stuart Robert K.¹,Arellano Martha L.¹,Slack James L.¹,Sekeres Mikkael A.¹,Willekens Christophe¹,Choe Sung¹,Wang Hongfang¹,Zhang Vickie¹,Yen Katharine E.¹,Kapsalis Stephanie M.¹,Yang Hua¹,Dai David¹,Fan Bin¹,Goldwasser Meredith¹,Liu Hua¹,Agresta Sam¹,Wu Bin¹,Attar Eyal C.¹,Tallman Martin S.¹,Stone Richard M.¹,Kantarjian Hagop M.¹

Affiliation:

1. From the University of Texas M.D. Anderson Cancer Center, Houston (C.D.D., H.M.K.); Memorial Sloan Kettering Cancer Center (E.M.S., M.S.T.) and Weill Cornell Medical College (G.J.R.), New York; Institut Gustave Roussy, Villejuif (S.B., C.W.), and Centre Hospitalier Universitaire Bordeaux, Bordeaux (A.P.) — both in France; Northwestern University, Chicago (J.K.A.); Ohio State University Wexner Medical Center, Columbus (A.S.M.); Sylvester Comprehensive Cancer Center, University of Miami, Miami (R.S.);...

Funder

Agios Pharmaceuticals, Inc.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1716984

Cited by 1136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relapse and resistance in acute myeloid leukemia post venetoclax: improving second lines therapy and combinations;Expert Review of Hematology;2024-09-13

2. Management of Acute Myeloid Leukemia in Patients under 60 Years of Age;Advances in Hematological Malignancies [Working Title];2024-09-11

3. Prevalence of IDH1/IDH2 Mutations in Adult Indian Acute Myeloid Leukaemia Patients and Their Impact on Outcome;Indian Journal of Hematology and Blood Transfusion;2024-09-05

4. Beyond glucose and Warburg: finding the sweet spot in cancer metabolism models;npj Metabolic Health and Disease;2024-09-02

5. Drug resistance in human cancers — Mechanisms and implications;Life Sciences;2024-09